Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_assertion type Assertion NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_head.
- NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_assertion description "[By inhibiting the BCL9-?-catenin interaction and selectively suppressing oncogenic Wnt transcription, SAH-BCL9 may serve as a prototype therapeutic agent for cancers driven by deregulated Wnt signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_provenance.
- NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_assertion evidence source_evidence_literature NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_provenance.
- NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_assertion SIO_000772 22914623 NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_provenance.
- NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_assertion wasDerivedFrom befree-20150227 NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_provenance.
- NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_assertion wasGeneratedBy ECO_0000203 NP265191.RAwBAkn2qxtpcOOArEf2vbuxqvw2aFYig8FXqQissGVmE130_provenance.